TrialResults - center   -  Clinical trials results database in cardiology

GAMMA

You are here:  Home > Search and browse > Browse treatment 3

Clinical trials of troglitazone

Clinical trials of troglitazone and meta-analysis are available for the following clinical conditions:

diabetes

diabetes, prevention, all type of patients

troglitazone vs placebo :  TRIPOD (Buchanan), 2002  -  US DDP troglitazone (Knowler), 2005  - 

diabetes, prevention, people with impaired glucose tolerance

troglitazone vs placebo :  TRIPOD (Buchanan), 2002  -  US DDP troglitazone (Knowler), 2005  - 

Entry terms: 5-(4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione), troglitazone, 5-(4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione), Prelay, Rezulin, Warner-Lambert brand of troglitazone, Parke Davis brand of troglitazone, CS 045, CS-045, 5-(4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)-2,4-dioxothiazollidine, troglitazone dihydrate, 5-(HTMCM)BD-troglitazone dihydrate, troglitazone sulfate, TGZS cpd

See also relatic topics:

• prevention
• prevention in atrial fibrillation
• prevention in diabetes
• prevention in impaired fasting glucose
• prevention in post stroke

Search troglitazone clinical trials in Pubmed

Search troglitazone clinical trials in ClinicalTrials.gov

Search troglitazone clinical trials in Wikipedia

Search troglitazone in drugs.com

browse_trt3

This site complies to the HONcode standard for trustworthy health information: verify here.

Last uptaded on 2010/7 57 user(s) connected

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar